ArticleBlood science (Baltimore, Md.)2024

Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry study.

Mingyuan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.